WASHINGTON, DC—In PEERLESS, the first randomized controlled trial pitting two different interventional strategies against each other in pulmonary embolism (PE), patients with acute intermediate-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback